We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ZVSA ZyVersa Therapeutics Inc

0.0054 (0.91%)
Last Updated: 09:11:11
Delayed by 15 minutes


Draw Mode:

Volume 73,003
Bid Price 0.60
Ask Price 0.61
News -
Day High 0.612


52 Week Range


Day Low 0.59
Share Name Share Symbol Market Stock Type
ZyVersa Therapeutics Inc ZVSA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0054 0.91% 0.60 09:11:11
Open Price Low Price High Price Close Price Previous Close
0.60 0.59 0.612 0.5946
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
157 73,003 US$ 0.5986888 US$ 43,706 - 0.50 - 96.95
Last Trade Type Quantity Price Currency
09:24:31 13 US$ 0.605 USD

ZyVersa Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
27.97M 1.24M - 0 -75k -0.06 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ZyVersa Therapeutics News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ZVSA Message Board. Create One! See More Posts on ZVSA Message Board See More Message Board Posts

Historical ZVSA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.570.620.560.5870567178,0860.035.26%
1 Month0.640.68950.540.6085254258,833-0.04-6.25%
3 Months2.804.23850.501.531,455,424-2.20-78.57%
6 Months5.4957.97850.504.274,298,939-4.90-89.08%
1 Year79.4596.950.507.622,940,401-78.85-99.24%
3 Years490.00523.250.5010.432,554,447-489.40-99.88%
5 Years490.00523.250.5010.432,554,447-489.40-99.88%

ZyVersa Therapeutics Description

ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |